amylin glp-1 dual agonist Identification and utility exploration of a highly potent and long-acting bullfrog analogue in GLP-1 and combination therapy Novo's GLP-1/Amylin Dual Agonist Amycretin
Description
Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease

25% report they are no longer dieting, while 29% say they are dieting more than before

This twice daily injectable established the entire drug class

BMI, Body mass index

Lilly 2026 How Retatrutide Compares to Tirzepatide and Semaglutide Head-to-head network meta-analysis data shows retatrutide produces greater absolute and percentage weight loss than tirzepatide: a mean difference of 16.34 kg absolute weight reduction and 23.77% percentage weight loss versus tirzepatide's 16.79%
